Navigation Links
Sigma® Life Science Awarded Silver in Top Ten Innovations 2010
Date:12/2/2010

ST. LOUIS, Dec. 2, 2010 /PRNewswire/ -- Sigma Life Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq: SIAL), today announced that its genetically modified reporter cell lines – based on the CompoZr zinc finger nuclease (ZFN) technology – takes the silver medal position in The Scientist magazine's Top Ten Innovations for 2010. This latest award continues Sigma Life Science's track record of success in the magazine's prestigious life science innovation competition, following third place in 2008's inaugural awards for the CompoZr custom zinc finger nuclease service, and fifth place for SAGE™ Labs' SAGEspeed™ rat model creation process in 2009.

(Photo:  http://photos.prnewswire.com/prnh/20101202/CG11435)

This latest success recognizes the power of Sigma Life Science's CompoZr ZFN technology for genetic manipulation and underscores the potential of Sigma's newly launched portfolio of genetically modified mammalian cell lines for furthering fundamental understanding of cell biology and accelerating cell-based research. The proprietary ZFN technology allows precise insertion, substitution or deletion of genes of interest. Dave Smoller, president of Sigma Life Science, commented: "The power of ZFN technology is rapidly being recognized as the new benchmark for genetic manipulation and Sigma Life Science is dedicated to pushing the limits of this technology while, ensuring scientists have access to the research tools they need. Our ongoing success in The Scientist's Top Ten Innovations competition demonstrates our commitment to use the CompoZr platform to deliver innovative products that will help to drive scientific discovery."

This potent technology has been harnessed to create an exciting new range of genetically modified reporter cell lines, as well as specific isogenic lines initially designed to advance colorectal and breast cancer research. The first CompoZr cellular reporter cell lines were launched in November 2010, and have been optimized for live cell imaging applications. Incorporating fluorescent tags at endogenous loci of the genes of interest, these new offerings avoid the additional stresses and potential toxicity issues associated with protein overexpression in live cells, as well as eliminating the need for tedious staining procedures.

For more information about Sigma Life Science's cell line products, visit http://www.wherebiobegins.com/biocells.

Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "underscores the potential," "rapidly been recognized," "our commitment," "designed to advance" or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that CompoZr cell lines will achieve any particular levels of revenue in the future. In particular, management's expectations regarding CompoZr cell lines could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Sigma Life Science: Sigma Life Science is a Sigma-Aldrich business that represents the Company's leadership in innovative biological products and services for the global life science market and offers an array of biologically-rich products and reagents that researchers use in scientific investigation. Product areas include biomolecules, genomics and functional genomics, cells and cell-based assays, transgenics, protein assays, stem cell research, epigenetics and custom services/oligonucleotides. Sigma Life Science also provides an extensive range critical bioessentials like biochemicals, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, amino acids and their derivatives, and cell culture media.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company that is committed to enabling science to improve the quality of life. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. Sigma-Aldrich has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,700 employees providing excellent service worldwide. For more information about Sigma-Aldrich, please visit its award-winning website at http://www.sigma-aldrich.com.

Sigma-Aldrich, Sigma and CompoZr are trademarks of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma® Life Science Enters Genetically Modified Cell Market
2. The Pittsburgh Life Sciences Greenhouse Announces New Chairman of the Board
3. BioSpace Highlights the Northwests Growing Life Science Region
4. YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387
5. Call for Applications: The Amgen Award for Science Teaching Excellence
6. Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist
7. Ardea Biosciences to Present at Two Upcoming Investor Conferences
8. Elsevier Releases Image Search; New SciVerse ScienceDirect Feature Enables Researchers to Quickly Find Reliable Visual Content
9. YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
10. Stallergenes Welcomes Ares Life Sciences as a New Reference Shareholder
11. Ben-Gurion University nano researcher to receive prestigious award for laser science and quantum physics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 According ... Market Research "Separation Systems for Commercial Biotechnology Market ... and Forecast 2015 - 2023", the separation systems ... 10,665.5 Mn in 2014 and is projected to ... to 2023 to reach US$ 19,227.8 Mn in ...
(Date:4/28/2016)... 2016 The report "Cryocooler Market ... Service (Technical Support, Product Repairs & Refurbishment, Preventive Maintenance, ... to 2022", published by MarketsandMarkets, the global market is ... at a CAGR of 7.29% between 2016 and 2022. ... 94 Figures spread through 159 Pages and in-depth TOC ...
(Date:4/28/2016)... ... 28, 2016 , ... Morris Midwest ( http://www.morrismidwest.com ), a ... at its Maple Grove, Minnesota technical center, May 11-12. The event will ... Almost 20 leading suppliers of tooling, accessories, software and other related technology will ...
(Date:4/27/2016)... VANCOUVER, British Columbia , April 27, 2016 ... "Gesellschaft" oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... sie im Anschluss an ihre Pressemitteilung vom 13. ... Inc. erhalten hat, ihre Finanzen um zusätzliche 200.000.000 ... auf 4.000.000 Kanadische Dollar zu bringen. Davon wurden ...
Breaking Biology Technology:
(Date:3/15/2016)... March 15, 2016 Yissum Research Development ... technology-transfer company of the Hebrew University, announced today the ... sensing technology of various human biological indicators. Neteera Technologies ... million from private investors. ... the detection of electromagnetic emissions from sweat ducts, enables ...
(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/8/2016)... RALEIGH, N.C. , March 8, 2016 /PRNewswire/ ... biometric sensor technology, today announced it has secured ... led by GII Tech, a new venture fund ... LLC, with additional participation from existing investors TDF ... use the funds to continue its triple-digit growth ...
Breaking Biology News(10 mins):